Fundz

Ascensus Specialties Appoints Dr. Emma Sceats as Chief Executive Officer

PRIVATESep 17, 2026
New to company · from Abcam“Since joining Ascensus as the Chief Commercial Officer in January 2025, Emma has played a leading role... Prior to joining Ascensus, Dr. Sceats served as SVP of Marketing, Sales & Customer Service at Abcam”

Position

Chief Executive Officer

Company

Ascensus Specialties

Emma Sceats
ManufacturingBiotechnology

Description

Ascensus Specialties has appointed Dr. Emma Sceats as their new Chief Executive Officer, effective immediately. She succeeds Paul Burlingame, who will shift to an advisory role.

Quick answer

Ascensus Specialties Appoints Dr. Emma Sceats as Chief Executive Officer (September 17, 2026).

Who is the new Chief Executive Officer at Ascensus Specialties?
Ascensus Specialties named Emma Sceats Chief Executive Officer, announced September 17, 2026.
What did Ascensus Specialties announce on September 17, 2026?
Ascensus Specialties has appointed Dr. Emma Sceats as their new Chief Executive Officer, effective immediately. She succeeds Paul Burlingame, who will shift to an advisory role.
Where did Emma Sceats work before joining Ascensus Specialties?
Emma Sceats joins from Abcam.
What does Ascensus Specialties do?
Headquartered in Bellevue, WA, Ascensus Specialties LLC is a global leader in high performance specialty reagents, GMP & custom Synthesis, Catalysts, Ligands, CVD/ALD precursors, Specialty Intermediates, and API (Active...
Which similar companies made leadership changes around the same time?
Medtronic plc (September 17, 2026), Integris Medtech (September 17, 2026), Tirupati Group (September 18, 2026) and Glycovax Pharma (September 15, 2026) also announced leadership changes within 45 days of Ascensus Specialties.

Source: Fundz verified event record.

Other recent leadership changes in Manufacturing and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Ascensus Specialties, and when

A new leader at Ascensus Specialties brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Ascensus Specialties raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ascensus Specialties, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ascensus Specialties. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ascensus Specialties

About

Headquartered in Bellevue, WA, Ascensus Specialties LLC is a global leader in high performance specialty reagents, GMP & custom Synthesis, Catalysts, Ligands, CVD/ALD precursors, Specialty Intermediates, and API (Active Pharmaceutical Ingredient) Synthesis. Ascensus’ chemistries improve the way its clients create their products by making what they do easier, more efficient, safe and more selective. From world-class production sites in Elma, WA; Evans City, PA; Newburyport, MA; and Cambridge, UK, Ascensus has the global reach to ensure that clients can consistently manufacture their products to the highest standards on a global basis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ascensus Specialties changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Ascensus Specialties's next move

Learn about Strategic plan

Ascensus Specialties changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.